More valuable than platinum: first-line pembrolizumab in advanced stage non-small-cell lung cancer
- PMID: 28327984
- DOI: 10.1093/annonc/mdx083
More valuable than platinum: first-line pembrolizumab in advanced stage non-small-cell lung cancer
Comment on
-
Pembrolizumab as first-line therapy for patients with PD-L1-positive advanced non-small cell lung cancer: a phase 1 trial.Ann Oncol. 2017 Apr 1;28(4):874-881. doi: 10.1093/annonc/mdx008. Ann Oncol. 2017. PMID: 28168303 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources